215 related articles for article (PubMed ID: 27255164)
21. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
23. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
Eichhorn JH; Young RH; Clement PB; Scully RE
Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
[TBL] [Abstract][Full Text] [Related]
24. Müllerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases.
Clement PB
Am J Surg Pathol; 1989 Jan; 13(1):28-38. PubMed ID: 2535774
[TBL] [Abstract][Full Text] [Related]
25. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
Hum Pathol; 2024 Apr; 148():14-22. PubMed ID: 38688412
[TBL] [Abstract][Full Text] [Related]
26. Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):479-482. PubMed ID: 30122564
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
28. Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.
Mubeen A; Shahid M; Makary R
Pathologica; 2020 Dec; 112(4):219-223. PubMed ID: 33393526
[TBL] [Abstract][Full Text] [Related]
29. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetic characterization of a case of Müllerian adenosarcoma.
Chen Z; Hong B; Drozd-Borysiuk E; Coffin C; Albritton K
Cancer Genet Cytogenet; 2004 Jan; 148(2):129-32. PubMed ID: 14734223
[TBL] [Abstract][Full Text] [Related]
31. Adenosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases.
Blom R; Guerrieri C
Int J Gynecol Cancer; 1999 Jan; 9(1):37-43. PubMed ID: 11240741
[TBL] [Abstract][Full Text] [Related]
32. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
33. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
35. Pathologic quiz case. Uterine polypoid mass in a postmenopausal patient following tamoxifen treatment for breast cancer.
Mhawech P; Vlastos AT; Pelte MF
Arch Pathol Lab Med; 2002 Sep; 126(9):1125-6. PubMed ID: 12240628
[No Abstract] [Full Text] [Related]
36. Whole-Genome Sequencing and Target Validation Analysis of Müllerian Adenosarcoma: A Tumor With Complex but Specific Genetic Alterations.
Ban Y; Fischer JV; Maniar KP; Guo H; Zeng C; Li Y; Zhang Q; Wang X; Zhang W; Bulun SE; Wei JJ
Front Oncol; 2020; 10():538. PubMed ID: 32351899
[TBL] [Abstract][Full Text] [Related]
37. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
38. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
39. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
Kumar S; Raza M; Tariq MU
J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
[TBL] [Abstract][Full Text] [Related]
40. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
